In contrast with the other organs such as the lung, small cell tumors have been less studied in the breast due to their relatively less frequency. Although rare, neuroendocrine neoplasms, some lymphomas, and some small cell sarcomas such as undifferentiated small round cell sarcoma and rhabdomyosarcoma can be seen in small cell morphology in the breast. Many cytological specimens such as fine-needle aspiration biopsies and touch imprint cytology are used for diagnosis and further prognostic/predictive marker determination in primary breast masses, sentinel and axillary lymph nodes, and metastatic masses. Lobular carcinoma deserves to be considered in the small cell tumor group because of its small, monomorphic, discohesive, scant cytoplasmic cytological features. Since so many different types of tumors in the breast can have small cell characteristics, they should be divided into small cell neuroendocrine tumors and small cell nonneuroendocrine tumors. When evaluating small cell breast tumors cytologically, wide tumor diversity should be kept in mind, and clinical, hematological, and radiological features should be taken into consideration.

1.
La Rosa
S
,
Uccella
S
.
Classification of neuroendocrine neoplasms: lights and shadows
.
Rev Endocr Metab Disord
.
2021
;
22
(
3
):
527
38
. .
2.
Rindi
G
,
Klimstra
DS
,
Abedi-Ardekani
B
,
Asa
SL
,
Bosman
FT
,
Brambilla
E
,
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
.
Mod Pathol
.
2018
;
31
:
1770
86
.
3.
Uccella
S
,
La Rosa
S
,
Volante
M
,
Papotti
M
.
Immunohistochemical biomarkers of gastrointestinal, pancreatic, pulmonary, and thymic neuroendocrine neoplasms
.
Endocr Pathol
.
2018
;
29
:
150
68
. .
4.
Feyrter
F
,
Hartmann
G
.
On the carcinoid growth form of the carcinoma mammae, especially carcinoma solidum (gelatinosum) mammae
.
FrankfZ Pathol
.
1963
;
73
:
24
39
.
5.
Cubilla
AL
,
Woodruff
JM
.
Primary carcinoid tumor of the breast. A report of eight patients
.
Am J Surg Pathol
.
1977
;
1
:
283
92
.
6.
Bussolati
G
,
Gugliotta
P
,
Sapino
A
,
Eusebi
V
,
Lloyd
RV
.
Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast
.
Am J Pathol
.
1985
;
120
(
2
):
186
92
.
7.
Ellis
IO
,
Schnitt
SJ
,
Sastre-Garau
X
.
Pathology and genetics of the tumours of breast and female genital organs
.
Lyon
:
IARC Press
;
2003
.
8.
Sapino
A
,
Papotti
M
,
Righi
L
,
Cassoni
P
,
Chiusa
L
,
Bussolati
G
.
Clinical significance of neuroendocrine carcinoma of the breast
.
Ann Oncol
.
2001
;
12 Suppl 2
:
S115
7
. .
9.
Lakhani
SR
,
Ellis
IO
,
Schnitt
SJ
,
Tan
PH
,
Van de Vijver
MJ
.
World health organization classification of tumours of the breast
. 4th ed.
Lyon
:
IARC Press
;
2012
.
10.
Rakha
EA
,
Reis-Filho
JS
,
Sasano
H
,
Wu
Y
.
Neuroendocrine neoplasms: introduction
. In:
WHO Classification of Tumours Editorial Board Editors
, editors.
Breast tumours
. 5th ed.
Lyon
:
IARC
;
2019
.
Vol. 2
; p.
155
.
11.
Uccella
S
,
Finzi
G
,
Sessa
F
,
La Rosa
S
.
On the endless dilemma of neuroendocrine neoplasms of the breast: a journey through concepts and entities
.
Endocr Pathol
.
2020
;
31
(
4
):
321
9
. .
12.
Marchiò
C
,
Geyer
FC
,
Ng
CKY
,
Piscuoglio
S
,
de Filippo
MR
,
Cupo
M
,
The genetic landscape of breast carcinomas with neuroendocrine differentiation
.
J Pathol
.
2017
;
241
(
3
):
405
19
.
13.
Inno
A
,
Bogina
G
,
Turazza
M
,
Bortesi
L
,
Duranti
S
,
Massocco
A
,
Neuroendocrine carcinoma of the breast: current evidence and future perspectives
.
Oncologist
.
2016
;
21
(
1
):
28
32
.
14.
Tang
F
,
Wei
B
,
Tian
Z
,
Gilcrease
MZ
,
Huo
L
,
Albarracin
CT
,
Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges
.
Histopatholology
.
2011
;
59
(
1
):
106
15
.
15.
Rosen
LE
,
Gattuso
P
.
Neuroendocrine tumors of the breast
.
Arch Pathol Lab Med
.
2017
;
141
(
11
):
1577
81
. .
16.
Papotti
M
,
Gherardi
G
,
Eusebi
V
,
Pagani
A
,
Bussolati
G
.
Primary oat cell (neuroendocrine) carcinoma of the breast. Report of four cases
.
Virchows Arch A Pathol Anat Histopathol
.
1992
;
420
(
1
):
103
8
. .
17.
Osamura
RY
,
Matsui
N
,
Okubo
M
,
Chen
L
,
Field
AS
.
Histopathology and cytopathology of neuroendocrine tumors and carcinomas of the breast: a review
.
Acta Cytol
.
2019
;
63
(
4
):
340
6
. .
18.
Kelten Talu
C
,
Savli
TC
,
Huq
GE
,
Leblebici
C
.
Histopathological and clinical differences between primary breast carcinomas with neuroendocrine features and primary breast carcinomas mimicking neuroendocrine features
.
Int J Surg Pathol
.
2019
;
27
(
7
):
744
52
. .
19.
Kelten Talu
C
,
Leblebici
C
,
Kilicaslan Ozturk
T
,
Hacihasanoglu
E
,
Baykal Koca
S
,
Gucin
Z
.
Primary breast carcinomas with neuroendocrine features: clinicopathological features and analysis of tumor growth patterns in 36 cases
.
Ann Diagn Pathol
.
2018 Jun
;
34
:
122
30
. .
20.
Shohdy
KS
,
Attia
H
,
Mahmoud
N
,
Kassem
L
.
Primary primitive neuroectodermal tumor of the breast: analysis of clinical outcomes of twenty-one patients
.
Breast J
.
2020
;
26
(
9
):
1893
4
. .
21.
da Silva
BB
,
Lopes-Costa
PV
,
Pires
CG
,
Borges
RS
,
da Silva
RG
 Jr
.
Primitive neuroectodermal tumor of the breast
.
Eur J Obstet Gynecol Reprod Biol
.
2008
;
137
(
2
):
248
9
. .
22.
Shin
J
,
Kim
HJ
,
Kim
DY
,
Gong
G
,
Cho
KJ
.
Primary rhabdomyosarcoma of the breast: study of three cases at one institution with a review of primary breast sarcomas
.
J Pathol Transl Med
.
2019
;
53
(
5
):
308
16
. .
23.
Torres
V
,
Ferrer
R
.
Cytology of fine needle aspiration biopsy of primary breast rhabdomyosarcoma in an adolescent girl
.
Acta Cytol
.
1985
;
29
(
3
):
430
4
.
24.
Audino
AN
,
Setty
BA
,
Yeager
ND
.
Rhabdomyosarcoma of the breast in Adolescent and Young Adult (AYA) women
.
J Pediatr Hematol Oncol
.
2017
;
39
(
1
):
62
6
. .
25.
Cheah
CY
,
Campbell
BA
,
Seymour
JF
.
Primary breast lymphoma
.
Cancer Treat Rev
.
2014
;
40
(
8
):
900
8
. .
26.
Nicholson
BT
,
Bhatti
RM
,
Glassman
L
.
Extranodal lymphoma of the breast
.
Radiol Clin North Am
.
2016
;
54
(
4
):
711
26
. .
27.
Mohiuddin
Y
,
Hong
H
,
Juskevicius
R
.
Cytological features of diffuse large B-cell lymphoma can mimic metastatic carcinoma on fine needle aspiration cytology
.
Cytopathology
.
2013
;
24
(
5
):
340
2
. .
28.
Jaffe
ES
,
Ashar
BS
,
Clemens
MW
,
Feldman
AL
,
Gaulard
P
,
Miranda
RN
,
Best practices guideline for the pathologic diagnosis of breast implant-associated anaplastic large-cell lymphoma
.
J Clin Oncol
.
2020
;
38
(
10
):
1102
11
.
29.
Mucha Dufloth
R
,
Xavier-Júnior
JC
,
Moraes Neto
FA
,
Janoti dos Santos
K
,
Schmitt
F
.
Fine needle aspiration cytology of lobular breast carcinoma and its variants
.
Acta Cytol
.
2015
;
59
(
1
):
37
42
. .
30.
Rajesh
L
,
Dey
P
,
Joshi
K
.
Fine needle aspiration cytology of lobular breast carcinoma. Comparison with other breast lesions
.
Acta Cytol
.
2003
;
47
:
177
82
. .
31.
Hwang
S
,
Ioffe
O
,
Lee
I
,
Waisman
J
,
Cangiarella
J
,
Simsir
A
.
Cytologic diagnosis of invasive lobular carcinoma: Factors associated with negative and equivocal diagnoses
.
Diagn Cytopathol
.
2004
;
31
:
87
93
. .
32.
Mitra
S
,
Dey
P
.
Grey zone lesions of breast: potential areas of error in cytology
.
J Cytol
.
2015
;
32
(
3
):
145
52
. .
33.
Jayaram
G
,
Swain
M
,
Chew
MT
,
Yip
CH
.
Cytologic appearances in invasive lobular carcinoma of the breast. A study of 21 cases
.
Acta Cytol
.
2000
;
44
(
2
):
169
74
. .
34.
Elliott
RM
,
Shenk
RR
,
Thompson
CL
,
Gilmore
HL
.
Touch preparations for the intraoperative evaluation of sentinel lymph nodes after neoadjuvant therapy have high false-negative rates in patients with breast cancer
.
Arch Pathol Lab Med
.
2014
;
138
(
6
):
814
8
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.